Skip to content

To evaluate the safety and efficacy of rigid gas permeable contact lenses for the temporary correction of myopia in orthokeratology, a prospective, multicenter, randomized, open, parallel controlled, non-inferiority clinical trial

To evaluate the safety and efficacy of rigid gas permeable contact lenses for the temporary correction of myopia in orthokeratology, a prospective, multicenter, randomized, open, parallel controlled, non-inferiority clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083459
Enrollment
Unknown
Registered
2024-04-25
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive error

Interventions

Experimental group:Wear rigid breathable contact lenses for orthokeratology produced by Mingyue Lenses Co., LTD. (Model: MYNK, specification: None)

Sponsors

Eye & ENT Hospital of Fudan University/West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. 8 years old = age =40 years old, gender is not limited; 2. Myopia =4.00D, and normal astigmatism < 1.75D, inverse astigmatism, oblique axis astigmatism < 1.00D; 3. Those who are expected to complete all follow-up tasks and can wear lenses as required; 4. Be able to understand the purpose of the trial, be willing to participate in the clinical trial, and sign the informed consent, in which the subjects under the age of 18 also require their legal guardians to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Primary optometry, the best corrected visual acuity 48.00D; 10. Unstable diopter; 11. Irregular corneal astigmatism; 12. Dominant strabismus; 13. Abnormal IOP (IOP 21mmHg); 14. Tear film rupture time test results =5s; 15. The polymorphic changes of corneal endothelium were evaluated as grade 4; 16. Researchers believe that fundus abnormalities affecting contact lens wearing; 17. Patients who have worn rigid breathable contact lenses or rigid contact lenses for orthokeratology within 1 month before screening (including participants in clinical trials); 18. Participants who have participated in drug clinical trials within 3 months before screening; 19. Allergic patients who have used contact lenses and/or care products; 20. Women who are pregnant, breastfeeding or planning to become pregnant (pregnancy testing is required for women of childbearing age); 21. Unable to understand the limitations and reversibility of orthokeratology to correct myopia; 22. The examination results indicate that there are other contraindications to wear or are not suitable for wearing orthokeratology glasses; 23. Other circumstances in which the investigator determines that the subject is not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Product effectiveness at 30 days of wear;

Secondary

MeasureTime frame
Uncorrected visual acuity;diopter;Important parameters related to corneal topography (flat K, steep K, ?K);

Countries

China

Contacts

Public ContactZhou Xingtao/Liu Longqian

Eye & ENT Hospital of Fudan University/West China Hospital of Sichuan University

xingtaozhou@163.com+86 138 1688 0725

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026